Many adamantane derivatives have been demonstrated to function as 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors. 3-Amino-N-adamantyl-3-methylbutanamide derivatives were optimized by structure-based drug design. Compound 8j exhibited a good in vitro and ex vivo inhibitory activity against both human and mouse 11β-HSD1.
Keywords: 11β-Hydroxysteroid dehydrogenase type 1 inhibitor; 3-Amino-N-adamantyl-3-methylbutanamide; Anti-diabetes; Structure-based drug design.
Copyright © 2014 Elsevier Ltd. All rights reserved.